New cancer drug TJ101 enters first human trials for advanced tumors
Disease control
Recruiting now
This Phase 1 trial is testing TJ101, an experimental antibody-drug conjugate that delivers chemotherapy directly to cancer cells. It is for adults with advanced or metastatic solid tumors (lung, prostate, esophageal, and others) who have run out of standard options. The study aim…
Phase: PHASE1 • Sponsor: Phrontline Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC